FAK inhibitor APG-2449 and CDK4/6 inhibitor palbociclib synergistically suppress mesothelioma tumor growth via autophagy induction
Home » FAK inhibitor APG-2449 and CDK4/6 inhibitor palbociclib synergistically suppress mesothelioma tumor growth via autophagy induction
2022
Tao R, Fang DD, Li Y, Zhai G, Zhou F, Wang Q, Deng J, Yang D, Zhai Y. FAK inhibitor APG-2449 and CDK4/6 inhibitor palbociclib synergistically suppress mesothelioma tumor growth via autophagy induction. Cancer Res. [Poster presented at: AACR Annual Meeting 2022; April 8-13, 2022; New Orleans, LA]. vol. 82 no. (suppl 12):, pp. 2563-2563, doi: 10.1158/1538-7445.AM2022-2563